Enhanc3D Genomics is a functional genomics company exploring the 3D organization of DNA in health and disease.
Enhanc3D Genomics has raised $5.4M in total funding. The most recent round was Series A. The last funding was announced in September 2025.
Enhanc3D Genomics's investors include Business Growth Fund, Parkwalk Advisors, Bioqube Ventures, Johnson & Johnson Robotics and Digital Solutions, Start Codon.
Enhanc3D Genomics is headquartered in Cambridge, United Kingdom.
Enhanc3D Genomics is a functional genomics company exploring the 3D organization of DNA in health and disease.
Enhanc3D Genomics is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Enhanc3D Genomics — Funding & Investors." VCBacked, September 16, 2025, https://www.vcbacked.co/company/enhanc3d-genomics. Accessed July 20, 2026.
VCBacked. (2025). Enhanc3D Genomics — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/enhanc3d-genomics
{{cite web |title=Enhanc3D Genomics — Funding & Investors |url=https://www.vcbacked.co/company/enhanc3d-genomics |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated